Thursday, 12 November 2026
M
Meridian Globe
Live briefing

Glycolipid-lectin driven endocytosis as a therapeutic vulnerability in breast cancer

Source Nature 生命科学16h ago
Summary

We index headlines and summaries only. Full content and copyright remain with the original publisher — follow the source link to read it.

Open original
Desk
Science
Region
Global
Language
English
Item ID
science-45e8db6f

Comments 0 comments

No comments yet. Be the first.

Glycolipid-lectin driven endocytosis as a therapeutic vulnerability in breast cancer · Meridian Globe